NCT06056193View on ClinicalTrials.gov

The SIR-POBA Bypass Trial

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 20, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2027

Conditions
Peripheral Arterial Occlusive DiseaseBypass ComplicationFemoropopliteal Artery OcclusionFemoropopliteal StenosisCritical Limb-Threatening IschemiaClaudication, Intermittent
Interventions
PROCEDURE

Balloon Angioplasty

Revascularisation procedures will be performed according to randomised list

Trial Locations (1)

5020

University Hospital of Salzburg, Paracelsus Medical University, Salzburg

Sponsors
All Listed Sponsors
collaborator

MedAlliance Swiss Medical Technology

UNKNOWN

lead

Paracelsus Medical University

OTHER

NCT06056193 - The SIR-POBA Bypass Trial | Biotech Hunter | Biotech Hunter